Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s Disease

ABSTRACT: Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s Disease

PROVIDER: PRJNA729525 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14514000_1.fastq.gz	Fastqsanger.gz
	SRR14514000_2.fastq.gz	Fastqsanger.gz
	SRR14514100_1.fastq.gz	Fastqsanger.gz
	SRR14514100_2.fastq.gz	Fastqsanger.gz
	SRR14514200_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 750

Similar Datasets

Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s Disease

Project description:The gene-regulatory landscape of the brain is highly dynamic in health and disease, coordinating a menagerie of biological processes across¬ distinct cell-types. Here, we present a multi-omic single-nucleus study of 191,890 nuclei in late-stage Alzheimer’s Disease (AD), accessible through our intuitive web portal, profiling chromatin accessibility and gene expression in the same biological samples and uncovering vast cellular heterogeneity. We identified cell-type specific, disease-associated candidate cis-regulatory elements and their candidate target genes, including an oligodendrocyte-associated regulatory module containing links to APOE and CLU. We describe cis-regulatory relationships in specific cell-types at AD risk loci defined by genome wide association studies (GWAS), demonstrating the utility of this multi-omic single-nucleus approach. Trajectory analysis of glial populations identified disease-relevant transcription factors, like SREBF1 and their regulatory targets. Further, we introduce scWGCNA, a co-expression network analysis strategy robust to the sparsity of single-cell data, to perform a systems-level meta-analysis of AD transcriptomics.

2021-05-12 | GSE174367 | GEO

Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model

Project description:Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model

| PRJNA608710 | ENA

Single-nucleus RNA-Seq and spatial transcriptomics characterization of Alzheimer’s Disease and Down Syndrome

Project description:The highly dynamic regulatory networks involved in brain processes can result in specific gene expression patterns across distinct cell types. The single-nucleus and spatial transcriptomics data allow us to better understand these patterns. This study involved the analyses of the brains of mice and humans with Alzheimer’s Disease (AD) and Down Syndrome.

2024-09-12 | GSE233208 | GEO

Single-nucleus RNA-Seq and spatial transcriptomics characterization of Alzheimer’s Disease and Down Syndrome

Project description:Single-nucleus RNA-Seq and spatial transcriptomics characterization of Alzheimer’s Disease and Down Syndrome

| PRJNA975472 | ENA

Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease.

Project description:The gene-regulatory landscape of the brain is highly dynamic in health and disease, coordinating a menagerie of biological processes across distinct cell types. Here, we present a multi-omic single-nucleus study of 191,890 nuclei in late-stage Alzheimer's disease (AD), accessible through our web portal, profiling chromatin accessibility and gene expression in the same biological samples and uncovering vast cellular heterogeneity. We identified cell-type-specific, disease-associated candidate cis-regulatory elements and their candidate target genes, including an oligodendrocyte-associated regulatory module containing links to APOE and CLU. We describe cis-regulatory relationships in specific cell types at a subset of AD risk loci defined by genome-wide association studies, demonstrating the utility of this multi-omic single-nucleus approach. Trajectory analysis of glial populations identified disease-relevant transcription factors, such as SREBF1, and their regulatory targets. Finally, we introduce single-nucleus consensus weighted gene coexpression analysis, a coexpression network analysis strategy robust to sparse single-cell data, and perform a systems-level analysis of the AD transcriptome.

| S-EPMC8766217 | biostudies-literature

Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model (ATAC-Seq)

Project description:Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model (ATAC-Seq)

| PRJNA608708 | ENA

Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model (RNA-Seq)

Project description:Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model (RNA-Seq)

| PRJNA608711 | ENA

Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer’s Disease

Project description:The linear sequence of amino acids in a protein folds into a 3D structure to execute protein activity and function, but it is still challenging to profile the 3D structure at the proteome scale. Here, we present a method of native protein tandem mass tag (TMT) profiling of Lys accessibility and its application to investigate structural alterations in human brain specimens of Alzheimer’s disease (AD).

2021-03-23 | PXD024914 | Pride

Single-nucleus RNA sequencing of dorsolateral prefrontal cortex from normal, pathological aging, and Alzheimer’s disease human brains

Project description:We performed single-nucleus RNA sequencing of the dorsolateral prefrontal cortex from 15 normal, pathological aging, and Alzheimer’s disease human brains that varied by APOE and TREM2 genotype to analyze cell-type specific transcriptomic changes across the range of Alzheimer’s disease pathology and genetic risk factors.

2023-10-02 | GSE243292 | GEO

Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease

Project description:Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease

| PRJNA615180 | ENA